Arvee Laboratories (India) (NSE:ARVEE) Beneish M-Score: -1.92 (As of Jul. 03, 2026)


NSE:ARVEE Arvee Laboratories (India) Ltd NSE:ARVEE
74 GF Score
Price ₹164.96
GF Value ₹123.73
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Arvee Laboratories (India) Beneish M-Score?

Arvee Laboratories (India) NSE:ARVEE +1.41% 74 Beneish M-Score is -1.92 as of Jul. 03, 2026. GuruFocus rates NSE:ARVEE with a GF Score™ of 74/100 and a GF Value™ of ₹123.73 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,527 Chemicals companies, Arvee Laboratories (India) ranks worse than 81.01% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Arvee Laboratories (India)'s Beneish M-Score or its related term are showing as below:

NSE:ARVEE' s Beneish M-Score Range Over the Past 10 Years
Min: -3.9   Med: -2.35   Max: -1.15
Current: -1.92

During the past 13 years, the highest Beneish M-Score of Arvee Laboratories (India) was -1.15. The lowest was -3.90. And the median was -2.35.


Arvee Laboratories (India) Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Arvee Laboratories (India)'s Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvee Laboratories (India) Beneish M-Score Chart

Arvee Laboratories (India) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.28 -1.15 -1.63 -2.86 -1.92

Arvee Laboratories (India) Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1.92 0.00 0.00 0.00

NSE:ARVEE vs LIN, SHW, ECL: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvee Laboratories (India) Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Arvee Laboratories (India)'s Beneish M-Score falls into.


NSE:ARVEE
74GF Score
Arvee Laboratories (India) Ltd NSE:ARVEE
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvee Laboratories (India) Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Arvee Laboratories (India) for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0869+0.528 * 1.0857+0.404 * 0.3125+0.892 * 1.2668+0.115 * 1.3312
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8897+4.679 * 0.062636-0.327 * 0.6138
=-1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was ₹84.7 Mil.
Revenue was ₹384.4 Mil.
Gross Profit was ₹135.1 Mil.
Total Current Assets was ₹196.6 Mil.
Total Assets was ₹375.7 Mil.
Property, Plant and Equipment(Net PPE) was ₹160.0 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹11.5 Mil.
Selling, General, & Admin. Expense(SGA) was ₹25.6 Mil.
Total Current Liabilities was ₹38.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹10.3 Mil.
Net Income was ₹21.5 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹-2.1 Mil.
Total Receivables was ₹61.5 Mil.
Revenue was ₹303.4 Mil.
Gross Profit was ₹115.8 Mil.
Total Current Assets was ₹169.8 Mil.
Total Assets was ₹385.6 Mil.
Property, Plant and Equipment(Net PPE) was ₹152.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹15.0 Mil.
Selling, General, & Admin. Expense(SGA) was ₹22.7 Mil.
Total Current Liabilities was ₹71.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹10.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(84.706 / 384.384) / (61.517 / 303.422)
=0.220368 / 0.202744
=1.0869

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(115.773 / 303.422) / (135.092 / 384.384)
=0.381558 / 0.351451
=1.0857

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (196.635 + 159.955) / 375.743) / (1 - (169.795 + 152.929) / 385.632)
=0.050974 / 0.16313
=0.3125

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=384.384 / 303.422
=1.2668

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(14.994 / (14.994 + 152.929)) / (11.501 / (11.501 + 159.955))
=0.089291 / 0.067078
=1.3312

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(25.636 / 384.384) / (22.746 / 303.422)
=0.066694 / 0.074965
=0.8897

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10.333 + 38.272) / 375.743) / ((10 + 71.265) / 385.632)
=0.129357 / 0.210732
=0.6138

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(21.473 - 0 - -2.062) / 375.743
=0.062636

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Arvee Laboratories (India) has a M-score of -1.92 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.92 mean?
Arvee Laboratories (India) (NSE:ARVEE) has a Beneish M-Score of -1.92 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Arvee Laboratories (India) and its competitors. According to the industry distribution chart, Arvee Laboratories (India) ranks #1237 out of 1527 companies in the Chemicals industry, placing it in the top 81%.
Is Arvee Laboratories (India)'s Beneish M-Score too high?
Arvee Laboratories (India)'s current Beneish M-Score is -1.92. Based on the distribution chart, Arvee Laboratories (India) ranks #1237 out of 1527 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Arvee Laboratories (India) has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvee Laboratories (India)'s Beneish M-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Arvee Laboratories (India) ranks #1237 out of 1527 companies for Beneish M-Score. This places Arvee Laboratories (India) in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Arvee Laboratories (India) and its competitors. Arvee Laboratories (India)'s current Beneish M-Score is -1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvee Laboratories (India) stock overvalued right now?
Based on GuruFocus' analysis, Arvee Laboratories (India) (NSE:ARVEE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹123.73, compared to a current price of ₹164.96 — trading 33.3% above its estimated fair value. The current Beneish M-Score is -1.92. Arvee Laboratories (India)'s overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Arvee Laboratories (India) (NSE:ARVEE), the current Beneish M-Score is -1.92 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvee Laboratories (India) (NSE:ARVEE) Overvalued in 2026?

Based on GuruFocus' analysis, Arvee Laboratories (India) stock appears to be overvalued. The current stock price of ₹164.96 is trading 33.3% above its estimated GF Value™ of ₹123.73. GuruFocus considers Arvee Laboratories (India) to be Significantly Overvalued.

Key valuation signals for NSE:ARVEE:

  • Beneish M-Score: -1.92
  • GF Value™: ₹123.73 vs. price of ₹164.96 (33.3% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the NSE:ARVEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvee Laboratories (India) Business Description

Address Iskcon Bopal Road, 403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop, Ambli, Ahmedabad, GJ, IND, 380058
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
74GF Score

Get the complete analysis for NSE:ARVEE

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹164.96
Price
₹123.73
GF Value